Technetium Tc99m Sestamibi Medication Information

Learn everything you need to know about Technetium Tc99m Sestamibi-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it.

Get up-to-date information on side effects, precautions, warnings, and proper storage to ensure safe usage.

Explore Technetium Tc99m Sestamibi brand names commonly used in India and internationally, along with detailed pricing information. Consult your healthcare provider for tailored medical advice.

Generic Name : Technetium Tc99m Sestamibi

ICD Code : Y57.6 Therapeutic Classification : Diagnostic Agents

Brand Names or Trade Names of Technetium Tc99m Sestamibi

International :

Miraluma

Why is Technetium Tc99m Sestamibi Prescribed? (Indications)

This medication is a radioactive pharmaceutical agent, prescribed for detecting coronary artery disease and breast lesions.

What is the dosage of Technetium Tc99m Sestamibi?

For Myocardial Imaging- IV- The recommended dose is 370-1110 MBq (10-30 mCi).
For Breast Imaging- The recommended dose is 740-1110 MBq (20 - 30 mCi).

How should Technetium Tc99m Sestamibi be taken?

It comes as a solution for injection, to be administered by a healthcare provider into the vein.

What are the warnings and precautions for Technetium Tc99m Sestamibi?

• It should be administered only by well-trained qualified physicians.

• Caution should be exercised in patients with history of kidney or liver disease, elderly, children, during pregnancy and breastfeeding.

What are the side effects of Technetium Tc99m Sestamibi?

Joint inflammation, angioedema, abnormal heart rhythm, dizziness, fainting, abdominal pain, nausea, headache, vomiting, and severe hypersensitivity characterized by difficulty in breathing, low blood pressure, slow heart rate, weakness, and vomiting.